Skip to Content

Robitussin Multi-Symptom Cold CF Prices, Coupons and Patient Assistance Programs

Robitussin Multi-Symptom Cold CF (dextromethorphan/guaifenesin/phenylephrine) is a member of the upper respiratory combinations drug class and is commonly used for Cough and Nasal Congestion.

Robitussin Multi-Symptom Cold CF Prices

The cost for Robitussin Multi-Symptom Cold CF oral liquid (20 mg-200 mg-10 mg/10 mL) is around $13 for a supply of 118 milliliters, depending on the pharmacy you visit. Prices are for cash paying customers only and are not valid with insurance plans.

This Robitussin Multi-Symptom Cold CF price guide is based on using the Drugs.com discount card which is accepted at most U.S. pharmacies.

Oral Liquid

Drugs.com Printable Discount Card

The free Drugs.com Discount Card works like a coupon and can save you up to 80% or more off the cost of prescription medicines, over-the-counter drugs and pet prescriptions.

Print Free Discount Card

Please note: This is a drug discount program, not an insurance plan. Valid at all major chains including Walgreens, CVS Pharmacy, Target, WalMart Pharmacy, Duane Reade and 65,000 pharmacies nationwide.

Robitussin Multi-Symptom Cold CF Coupons and Rebates

Robitussin Multi-Symptom Cold CF offers may be in the form of a printable coupon, rebate, savings card, trial offer, or free samples. Some offers may be printed right from a website, others require registration, completing a questionnaire, or obtaining a sample from the doctor's office.

Receive a printable coupon and save on your next purchase of any one Robitussin product; must complete online form; 1 coupon per purchase.

Applies to:
Robitussin Multi-Symptom Cold CF
Number of uses:
One coupon per purchase

More information please phone: 800-762-4675 Visit Website

Patient Assistance Programs for Robitussin Multi-Symptom Cold CF

Patient assistance programs (PAPs) are usually sponsored by pharmaceutical companies and provide free or discounted medicines to low income or uninsured and under-insured people who meet specific guidelines. Eligibility requirements vary for each program.

There are currently no Patient Assistance Programs that we know about for this drug.